CONNECT: Connecting Cerebral Organoids to the Blood-Brain Barrier

CONNECT: Connecting Cerebral Organoids to the Blood-Brain Barrier

The CONNECT project aims to develop a novel organoid-chip connecting the blood vasculature to the brain to mimic the blood-brain barrier (BBB). This complex 3D-model can be used to mimic aspects of drug delivery into the human brain, a key process that is often not...
How to bring innovation to the drug development space

How to bring innovation to the drug development space

Innovation is not only part of InnoSer’s name but is central to its activities. We believe, the solution for the continuously high drug attrition rates resides in addressing the problem already at the preclinical stages of drug development. More specifically, we aim...
Nano+ Project Ends With Promising Results

Nano+ Project Ends With Promising Results

Currently with no known cure, Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease that affects nerve cells in the brain and spinal cord. InnoSer has recently finished a project with promising results in understanding altered...
A day in the life of InnoSer Oncology Study Director Kim Frederix

A day in the life of InnoSer Oncology Study Director Kim Frederix

To provide a range of innovative tools for accelerating drug development, InnoSer brings people from both scientific and business backgrounds together. With our interview series ‘A day in the life of’, let’s take a glimpse into what it is like to be part of this small...
A day in the life of InnoSer senior research associate Sarah Aerts

A day in the life of InnoSer senior research associate Sarah Aerts

To provide a range of innovative tools for accelerating drug development, InnoSer brings people from both scientific and business backgrounds together. With our interview series ‘A day in the life of’, let’s take a glimpse into what it is like to be part of this small...